A competitive edge through research and development. As a developer and manufacturer of pain management systems operating under our certified quality management system in accordance with DIN EN ISO 13485, we adhere strictly to the principle of continuous improvement (CIP). In collaboration with research institutions such as the Fraunhofer Institute and physicists/developers such as Dr Ing. Dr rer. nat. Thorsten Stüker, we strive to adapt our microcurrent therapy system, the LuXXaMed HD2000+, to the wishes and suggestions of our customers as well as to the current state of the art.

This has resulted in a new software version for the HD2000+. Fundamental changes have been made to the user interface, usability and therapeutic/medical applications. Furthermore, in response to numerous customer requests, we have implemented a module for FSM – Frequency-Specific Microcurrent Therapy – into the HD2000+ microcurrent device.

The new HD2000+ software offers users (doctors, physiotherapists, alternative practitioners and occupational therapists) the opportunity to utilise a technology in the treatment of pain and neurological conditions using microcurrent that comes close to that of AI (artificial intelligence).

Data can be imported from software version 2.0 into the new version; furthermore, a data analysis tool allows therapy data to be analysed on a PC or Mac. A new update mechanism also allows future updates to be carried out via the Apple iPad Pro and the LuXXaMed Panel PC. The necessary update files can be conveniently provided via email or as a download to individual devices.